首页> 外文期刊>Future medicinal chemistry >Review of bioactive secondary metabolites from marine bryozoans in the progress of new drugs discovery
【24h】

Review of bioactive secondary metabolites from marine bryozoans in the progress of new drugs discovery

机译:新药发现进程中海洋盐水中生物活性二次代谢产物的回顾

获取原文
获取原文并翻译 | 示例
           

摘要

Marine bryozoans play an important role for the discovery of novel bioactive compounds among marine organisms. In this review, we summarize 164 new secondary metabolites including macrocyclic lactones, sterols, alkaloids, sphingolipids and so forth from 24 marine bryozoans in the last two decades. The structural features, bioactivity, structure-activity relationship, mechanism and strategies to address the resupply of these scarce secondary metabolites are discussed. The structural and bioactive diversity of the secondary metabolites from marine bryozoans indicated the possibility of using these compounds, especially bryostatin 1 (1), bryostatin analog(BA1), alkaloids (50, 53, 127-128 and 134-139), sphingolipids sulfates (148 and 149) and sulfur-containing aromatic compound (160), as the starting points for new drug discovery.
机译:海洋荆棘师在海洋生物体中发现新型生物活性化合物发挥着重要作用。 在本综述中,我们在过去二十年中总结了164名新的二次代谢产物,包括宏循环乳酸酯,甾醇,生物碱,鞘脂等24海洋盐结构。 讨论了解决这些稀缺的次要代谢产物的补充的结构特征,生物活性,结构 - 活动关系,机制和策略。 来自海洋盐酸盐的次生代谢物的结构和生物活性多样性表明了使用这些化合物,尤其是苔藓抑素1(1),苔藓抑素(BA1),生物碱(50,53,127-128和134-139),硫酸盐(50,53,127-128和134-139)的可能性 (148和149)和含硫芳族化合物(160),作为新药发现的起点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号